Literature DB >> 19236776

[Effects of Tanshinone IIa on cytokines and platelets in immune vasculitis and its mechanism].

Xiao-Jing Li1, Min Zhou, Xiao-Hui Li, You-Hua Xu, Hong Liu, Mo Yang.   

Abstract

The objective of this study was to investigate the effect of Tanshinone IIa on IL-1beta, IL-6 and TNF-alpha cytokines in immune vasculitis and platelets, as well as their relationship. The model of immune vasculitis of rabbits were established by intravenous injection of bovine serum albumin twice. Experiment was divided into 4 groups: control group, model group, tanshinone IIa-treated group and aspirin-treated group. The platelet count, platelet aggregation of peripheral blood were determined. The levels of serum IL-1beta, IL-6, TNF-alpha were detected by ELISA. The pathological changes of immune vasculitis were analyzed by hematoxylin &amp; eosin staining, elastic fibers staining and electron microscopy. The results showed that the levels of IL-1beta and TNF-alpha in model group were significantly higher than those in normal group (p < 0.05), while the level of IL-6 was not significantly different between various groups. The serum level of IL-1beta was correlated with platelet number, while serum levels IL-1beta and TNF-alpha were both correlated with the platelet aggregation. The treatment with tanshinone IIa could significantly decrease the serum levels of IL-1beta, TNF-alpha and platelet number, and the efficacy of tanshinone IIa was same as aspirin. The tanshinone IIa and aspirin both could alleviate the vessels damage in patients with immune vasculitis. It is concluded that the tanshinone IIa may diminish the inflammation damage of vessels in patients with immune vasculitis through the inhibition of cytokines and platelets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236776

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  3 in total

1.  Tanshinone IIA: A Promising Natural Cardioprotective Agent.

Authors:  Qinghua Shang; Hao Xu; Li Huang
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-06       Impact factor: 2.629

2.  Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: a randomized controlled trial.

Authors:  Siming Li; Yang Jiao; Hanjay Wang; Qinghua Shang; Fang Lu; Li Huang; Jiangang Liu; Hao Xu; Keji Chen
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

3.  Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights.

Authors:  Dalia Elebeedy; Walid F Elkhatib; Ahmed Kandeil; Aml Ghanem; Omnia Kutkat; Radwan Alnajjar; Marwa A Saleh; Ahmed I Abd El Maksoud; Ingy Badawy; Ahmed A Al-Karmalawy
Journal:  RSC Adv       Date:  2021-09-01       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.